VOR
Vor Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · US
$18.04
+0.06%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.82
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$1.16
- EPS estimate
- -$0.69
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -19.6%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.69 | -$1.16 | Miss -68.12% | — |
| May 13, 2026 | -$0.75 | -$0.73 | Beat 2.67% | — |
| Nov 13, 2025 | -$3.06 | -$3.33 | Miss -8.82% | — |
| May 14, 2025 | -$0.25 | -$0.26 | Miss -4.00% | — |
| Mar 20, 2025 | -$0.34 | -$0.44 | Miss -29.41% | — |
| Nov 7, 2024 | -$0.40 | -$0.40 | In line | — |
| Aug 8, 2024 | -$0.41 | -$0.41 | In line | — |
| May 9, 2024 | -$0.37 | -$0.45 | Miss -21.62% | — |
| Mar 20, 2024 | -$0.49 | -$0.39 | Beat 20.41% | $12.2M |
| Aug 10, 2023 | -$0.42 | -$0.45 | Miss -7.14% | — |
| May 11, 2023 | -$0.38 | -$0.43 | Miss -13.16% | — |
| Mar 23, 2023 | -$0.56 | -$0.53 | Beat 5.36% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026